Remove journals pharmaceutical-technology pharmaceutical-technology-march-2023
article thumbnail

PM360 Announces the Selections for its 12th Annual Innovations Issue

PM360

NEW YORK, NY, December, 14 2023: The life sciences industry is built on innovation. From developing ground-breaking new medicines to implementing better ways to ensure patients can access and stay on therapy to experimenting with new technology that changes how care is delivered—innovation is at the heart of everything this industry does.

article thumbnail

Recent developments in stem cell therapies

European Pharmaceutical Review

So far, 2023 has seen several major developments in stem cell-based therapies. Yet over “the last two decades, rapid technological advances have led to the wide adoption of cell and gene therapy products for the treatment of a variety of disease states” according to Cundell et al. Stem cells have the ability to self-renew.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PM360 10th Annual ELITE 100 Open for Submissions

PM360

PM360 will then continue to accept entries until March 15, 2024, but anything after Feb. Established a decade ago, the PM360 ELITE honors 100 of the top individuals and marketing teams across the healthcare and life sciences industries each year. The initial deadline for submissions is February 23, 2024.

article thumbnail

Will AI Completely Transform the Patient Experience?

PM360

The New England Journal of Medicine runs a weekly diagnostic challenge tasking physicians with correctly identifying a thorny case. Generative AI, particularly in telehealth, offers immense opportunities to revolutionize healthcare interactions,” says Sulabh Agarwal, Chief Technology Officer, KeyCare. “AI-powered

Patients 111